01—Abstract
Summary
Summary of the 8-K filed June 5, 2026. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group Inc. (UNH) filed an 8-K report detailing the outcomes of its 2026 Annual Meeting of Shareholders, held on June 1, 2026.
The report indicates strong shareholder support for the company's leadership and financial oversight. All nine director nominees were overwhelmingly elected for one-year terms, reflecting confidence in the current board. Additionally, shareholders provided a non-binding advisory vote of approval for the company's executive compensation, with over 82%a of the votes cast in favor.
The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was also overwhelmingly ratified, underscoring shareholder confidence in the company's financial reporting and auditing processes. A notable outcome was the rejection of a shareholder proposal requesting an independent board chair.
This proposal received only approximately 20.24%b of the votes cast, indicating that the majority of shareholders do not believe such a policy change is necessary at this time. Overall, the meeting results suggest a generally positive sentiment among UNH shareholders regarding the company's governance, executive compensation, and auditor selection.
02—Key points
Key Highlights
- All nine director nominees were overwhelmingly elected to one-year terms at the 2026 Annual Meeting of Shareholders.
- Shareholders provided strong advisory approval (82.74% of votes cast) for UnitedHealth Group's executive compensation.
- The appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2026 was ratified with strong support (95.00% of votes cast).
- A shareholder proposal advocating for an independent board chair was not approved, receiving only 20.24% of the votes cast.
- A significant majority of common stock, 768,066,717 shares, was represented at the meeting, indicating substantial shareholder engagement.
03—Questions
Frequently Asked Questions
What were the main outcomes of the 2026 Annual Meeting of Shareholders?
The main outcomes include the election of all nine director nominees, advisory approval of executive compensation, ratification of the independent auditor (Deloitte & Touche LLP), and the rejection of a shareholder proposal for an independent board chair.
How did shareholders vote on executive compensation?
Shareholders approved the company's executive compensation through a non-binding advisory vote. Approximately 82.74% of the votes cast were in favor of the executive compensation plan.
Was the company's choice of auditor approved by shareholders?
Yes, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. Approximately 95.00% of the votes cast were in favor of this ratification.
What was the result of the shareholder proposal regarding an independent board chair?
The shareholder proposal requesting the adoption of a policy to require any board chair to be independent was not approved. It received approximately 20.24% of the votes cast in favor.
04—Continue